ArticleMedical science monitor : international medical journal of experimental and clinical research2018

Targeting mTORC1/2 Complexes Inhibit Tumorigenesis and Enhance Sensitivity to 5-Flourouracil (5-FU) in Hepatocellular Carcinoma: A Preclinical Study of mTORC1/2-Targeted Therapy in Hepatocellular Carcinoma (HCC).

Yu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.